© 2022 MJH Life Sciences and Contagion Live. All rights reserved.
© 2022 MJH Life Sciences™ and Contagion Live. All rights reserved.
Paul Monach, MD, PhD is chief of rheumatology at the VA Boston Healthcare System and a researcher focused on clinical trials. Monach is affiliated with Harvard Medical School.
February 14, 2022
A research agenda focusing on breakthrough infections, reinfections,
severity, and sequelae is needed to inform clinical practice when
COVID-19 emphasis shifts from eradication to living with the disease.
December 21, 2021
In the age of COVID-19, providers caring for patients with emerging diseases do not rely entirely on clinical guidelines, but also consult online resources that are updated more frequently. This needed integration helps providers adapt to the best-available evidence into bedside care when guidance is lacking.
Regdanvimab—A New Attack of the (Mono)Clones
FDA Lifts Clinical Hold of Lenacapavir for HIV Treatment and Prevention
First In-Africa Clinical Trial of mRNA HIV Vaccine
Fourth COVID-19 Vaccine Dose Boosts Immunity Above Third Shot